Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071338
Filing Date
2025-05-14
Accepted
2025-05-14 16:00:24
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20250331.htm   iXBRL 10-Q 1722631
2 EX-10.1 isco-ex10_1.htm EX-10.1 18886
3 EX-31.1 isco-ex31_1.htm EX-31.1 13621
4 EX-31.2 isco-ex31_2.htm EX-31.2 13575
5 EX-32.1 isco-ex32_1.htm EX-32.1 8587
6 EX-32.2 isco-ex32_2.htm EX-32.2 9192
  Complete submission text file 0000950170-25-071338.txt   8696273

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20250331.xsd EX-101.SCH 1040603
71 EXTRACTED XBRL INSTANCE DOCUMENT isco-20250331_htm.xml XML 1930771
Mailing Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131
Business Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 25945062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)